These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18177905)

  • 21. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
    Sacher J; Asenbaum S; Klein N; Geiss-Granadia T; Mossaheb N; Poetzi C; Attarbaschi T; Lanzenberger R; Spindelegger C; Rabas A; Heinze G; Dudczak R; Kasper S; Tauscher J
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serotonin transporter gene (SERT) DNA methylation is associated with bullying victimization and blunted cortisol response to stress in childhood: a longitudinal study of discordant monozygotic twins.
    Ouellet-Morin I; Wong CC; Danese A; Pariante CM; Papadopoulos AS; Mill J; Arseneault L
    Psychol Med; 2013 Sep; 43(9):1813-23. PubMed ID: 23217646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression.
    Joensuu M; Ahola P; Knekt P; Lindfors O; Saarinen P; Tolmunen T; Valkonen-Korhonen M; Vanninen R; Jääskeläinen T; Virtala E; Kuikka J; Tiihonen J; Lehtonen J
    Psychiatry Clin Neurosci; 2016 Jan; 70(1):34-41. PubMed ID: 26311446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.
    Hsu JW; Lirng JF; Wang SJ; Lin CL; Yang KC; Liao MH; Chou YH
    Bipolar Disord; 2014 May; 16(3):241-8. PubMed ID: 24372850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain.
    Reneman L; Booij J; Lavalaye J; De Bruin K; De Wolff FA; Koopmans RP; Stoof JC; Den Heeten GJ
    Synapse; 1999 Oct; 34(1):77-80. PubMed ID: 10459174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM.
    Zhao RJ; Lin SH; Lee LT; Lee IH; Chen PS; Chen KC; Yang YK
    J Addict Med; 2016; 10(2):89-92. PubMed ID: 26742023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of brain serotonin transporter availability and brain-derived neurotrophic factor in models of serotonin transporter genotypes in healthy subjects.
    Chou YH; Chen CK; Wang SJ; Tsai SJ; Lirng JF; Liou YJ; Lin CL; Yang KC; Lin MW; Lo WC; Liao MH; Chen CC
    J Clin Psychopharmacol; 2013 Jun; 33(3):432-5. PubMed ID: 23609403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midbrain binding of [123I]nor-beta-CIT in atypical depression.
    Lehto S; Tolmunen T; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Kuikka J; Lehtonen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1251-5. PubMed ID: 16644083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which demographic variables are necessary to correct in neuroimaging studies of serotonin transporter availability? A SPECT study with [¹²³I]ADAM.
    Chang WH; Lee LT; Lee IH; Chi MH; Chen KC; Chiu NT; Yao WJ; Chen PS; Yang YK
    Psychiatry Res; 2015 Mar; 231(3):320-4. PubMed ID: 25670644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low brain serotonin transporter binding in major depressive disorder.
    Newberg AB; Amsterdam JD; Wintering N; Shults J
    Psychiatry Res; 2012 May; 202(2):161-7. PubMed ID: 22698760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
    Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
    Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
    Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
    Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of body mass index with arterial stiffness and blood pressure components: a twin study.
    Tarnoki AD; Tarnoki DL; Bogl LH; Medda E; Fagnani C; Nisticò L; Stazi MA; Brescianini S; Lucatelli P; Boatta E; Zini C; Fanelli F; Baracchini C; Meneghetti G; Osztovits J; Jermendy G; Kiss RG; Preda I; Karlinger K; Lannert A; Molnar AA; Littvay L; Garami Z; Berczi V; Pucci G; Baffy G; Schillaci G; Pietiläinen KH
    Atherosclerosis; 2013 Aug; 229(2):388-95. PubMed ID: 23880193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
    Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
    J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy.
    Lehto SM; Tolmunen T; Joensuu M; Saarinen PI; Valkonen-Korhonen M; Vanninen R; Ahola P; Tiihonen J; Kuikka J; Lehtonen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):229-37. PubMed ID: 17884269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM.
    Yang YK; Yao WJ; Yeh TL; Lee IH; Chen KC; Lu RB
    Psychiatry Res; 2007 Apr; 154(3):281-4. PubMed ID: 17349781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation between mid-brain serotonin transporter availability and intelligence quotient in healthy volunteers.
    Tseng PY; Lee IH; Chen KC; Chen PS; Chiu NT; Yao WJ; Chu CL; Yeh TL; Yang YK
    Eur Psychiatry; 2015 Feb; 30(2):193-7. PubMed ID: 25447350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.